CAMBRIDGE, Mass.--(BUSINESS WIRE)--Effective today, Biogen Idec is known simply as Biogen (NASDAQ: BIIB).The company has introduced a new corporate identity and logo that reflect both its ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Biogen (NASDAQ: BIIB) today announced that Bioverativ will be the name of the standalone, publicly-traded global biotechnology company that it expects to launch ...

The Biogen Inc., headquarters is pictured on March 11, 2020, in Cambridge, Mass. Biogen is spending more than $7 billion to buy Reata Pharmaceuticals and bolster its rare disease treatments.